Your browser doesn't support javascript.
loading
A Clinician's Guide to Gluten Challenge.
Singh, Arunjot; Kleinhenz, Julia; Brill, Herbert; Fahey, Lisa; Silvester, Jocelyn A; Sparks, Brandon; Verma, Ritu; Lee, Dale; Mallon, Daniel; Leonard, Maureen M.
Afiliação
  • Singh A; From the Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Kleinhenz J; University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA.
  • Brill H; the Department of Pediatric Gastroenterology, Hepatology, and Nutrition, The University of Chicago, Chicago, IL.
  • Fahey L; the Division of Gastroenterology and Nutrition, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Silvester JA; the Department of Pediatrics, William Osler Health System, Etobicoke, Ontario, Canada.
  • Sparks B; the Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Verma R; From the Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Lee D; University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA.
  • Mallon D; the Celiac Research Program, Harvard Medical School, Boston, MA.
  • Leonard MM; the Department of Medicine, Boston Children's Hospital, Boston, MA.
J Pediatr Gastroenterol Nutr ; 77(6): 698-702, 2023 12 01.
Article em En | MEDLINE | ID: mdl-37608439
ABSTRACT
Gluten challenge is an essential clinical tool that involves reintroducing or increasing the amount of gluten in the diet to facilitate diagnostic testing in celiac disease (CD). Nevertheless, there is no consensus regarding the applications of gluten timing, dosing, and duration in children. This review aims to summarize the current evidence, discuss practical considerations, and proposes a clinical algorithm to help guide testing in pediatric patients. Childhood development, social circumstances, and long-term health concerns must be considered when identifying a candidate for gluten challenge. Based on previous studies, the authors suggest baseline serology followed by a minimum of 3-6 grams of gluten per day for over 12 weeks to optimize diagnostic accuracy for evaluation of CD. A formal provider check-in at 4-6 weeks is essential so the provider and family can adjust dosing or duration as needed. Increasing the dose of gluten further may improve diagnostic yield if tolerated, although in select cases a lower dose and shorter course (6-12 weeks) may be sufficient. There is consensus that mild elevations in celiac serology (<10 times the upper limit of normal) or symptoms, while supportive are not diagnostic for CD. Current North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines recommend histologic findings of intraepithelial lymphocytosis, crypt hyperplasia, and villous atrophy as the accurate and most appropriate endpoint for gluten challenge.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Celíaca / Glutens Tipo de estudo: Guideline / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Celíaca / Glutens Tipo de estudo: Guideline / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article